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Abstract The purpose of this work was to ascertain
whether liver mRNA species share common structural
features with hepatitis C virus (HCV) mRNA that allow
them to support the RNase-P (pre-tRNA/processing en-
zyme) cleavage reaction in vitro. The presence of RNase-P
competitive elements in the liver mRNA population was
determined by means of biochemical techniques, and a set
of sensitive mRNA species were identified through mi-
croarray screening. Cleavage specificity and substrate
length requirement of around 200 nts, were determined for
three mRNA species. One of these cleavage sites was
found in interferon-alpha 5 (IFNA5) mRNA between
specific base positions and with the characteristic RNase-P
chemistry of cleavage. It was mapped within a cloverleaf-
like structure revealed by a comparative structural analysis
based on several direct enzymes and chemical probing
methods of three RNA fragments of increasing size, and
subsequently contrasted against site-directed mutants. The
core region was coincident with the reported signal for the
cytoplasmic accumulation region (CAR) in IFNAs.
Striking similarities with the tRNA-like element of the
antagonist HCV mRNA were found. In general, this study
provides a new way of looking at a variety of viral tRNA-
like motifs as this type of structural mimicry might be
related to specific host mRNA species rather than, or in
addition to, tRNA itself.
Keywords RNA mimicry  RNase P  IFNA 
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Introduction
The ability of viral mRNAs to mimic tRNA was first dis-
covered more than 40 years ago after observing that the 30-
end of the turnip yellow mosaic virus (TYMV) was capable
of undergoing covalent linkage with amino acids catalyzed
by valyl-tRNA synthetase [1]. This and other plant viral
RNAs were subsequently observed to be accessible to a
battery of factors involved in other tRNA-related activities
[2, 3], including the accessibility of bacterial RNase P [4]
reviewed in [5–9]. Nevertheless, in vivo functional mimi-
cry was not complete, since plant viral RNAs were not
amino acid donors for protein synthesis but rather par-
ticipated in virus replication [10, 11].
RNase P specifically cleaves the tRNA precursor (pre-
tRNA) to produce its mature 50-end [12]. It contains an
RNA subunit required for activity [13] (with exceptions
[14, 15]), and represents an extremely conserved ribozyme
activity such that bacteria and human enzymes recognize
and correctly cleave each other’s pre-tRNA substrates. It is
found in virtually all organisms, with recognition depen-
dent on structural features of the RNA substrate rather than
sequence requirements [12, 16]; reviewed in [17–20].
RNase P is an accepted tool for detecting the presence of
Electronic supplementary material The online version of this
article (doi:10.1007/s00018-015-1908-0) contains supplementary
material, which is available to authorized users.
& Jordi Go´mez
jgomez@ipb.csic.es
1 Laboratorio de Arqueologı´a del RNA, Departamento de
Bioquı´mica y Biologı´a Molecular, Instituto de Parasitologı´a y
Biomedicina Lo´pez Neyra (IPBLN-CSIC), Armilla, Granada,
Spain
2 Centro de Investigacio´n Biolo´gica en Red de Enfermedades
Hepa´ticas y Digestivas (CIBERehd), Madrid, Spain
3 Present Address: Centro de Biologı´a Molecular Severo
Ochoa (UAM-CSIC) Cantoblanco, Madrid, Spain
Cell. Mol. Life Sci. (2015) 72:3747–3768
DOI 10.1007/s00018-015-1908-0 Cellular and Molecular Life Sciences
123
tRNA-like structures. Indeed RNase P cleavage studies led
to the identification of a number of verified tRNA-like
domains in non-tRNA molecules [4, 21–32]. In particular,
the RNase P from HeLa cells and the ribozyme moiety
from the cyanobacterium Synechocystis sp. were found to
cleave genomic HCV RNA near the AUG start triplet of
the internal ribosome entry site (IRES), thus suggesting a
similarity to tRNA [33, 34]. The cleavage region was
subsequently shown to adopt an L-shaped structure by
cryo-electron microscopy of HCV IRES/40S ribosomal
subunit complexes [35] and the use of bioinformatic tools
[36]. RNase P was also found to cleave the IRESs of the
related animal pestiviruses and the cricket paralysis virus
[37]. To date, tRNA-like motifs are the only common
structural element to have been found in viral IRES [37–
40]. It should be clarified that these are in vitro studies and
that there is no evidence that RNase P cleavage takes place
within the HCV lifecycle [41–43].
Herein we seek parallels between the known HCV
mRNA and the liver host mRNA, using two RNase P ac-
tivities of different origins and compositions i.e. human
RNase P and the ribozyme form Synechocystis sp. as
probing tools. First, we report a set of cellular mRNAs
carrying RNase P-sensitive motifs, and then we charac-
terize a motif in specific liver interferon-alpha subtype 5
(IFNA5) mRNA. The secondary structure determined
adopted a cloverleaf structure. It coincides with the most
conserved secondary structure region among all subtypes
of interferon-alpha mRNAs and with a large RNA signal
that mediates mRNA localization known as the cytoplas-
mic accumulation region (CAR).
This represents the first tRNA-like structure determined
within a human mRNA, thus sharing this property with
bacterial and a yeast mRNAs [24, 25, 44]. We also report
the subset of key experiments which indicate that both
RNase P activities specifically recognize regions of con-
siderable length in two other mRNAs (i.e. H2AFJ and
RSP9 mRNAs), thus making the presence of RNase P
substrate elements within mRNAs a putatively extended
feature throughout human mRNAs, and potential model
structures for viruses to mimic.
Materials and methods
DNA templates and in vitro transcription
The RNA transcripts used as standard substrates in the
RNase P assays were derived from plasmids, and were
performed as previously described [33]. The human genes
selected in this study, namely H2AFJ, RPS9 and IFNA5,
were cloned in pGEM3Zf(-) between the EcoR I and Hind
III cloning sites. H2AFJ and RPS9 cDNAs were obtained
from a human foetal liver cDNA library (Clontech) using
nested PCR with the following set of primers: first PCR
round for H2AFJ up GTAAAGAGTTTGTAGAGGCA and
for RPS9 up CTCTTTCTCAGTGACCGGGT and the
common down primer CTGCAGTTTTTTTTTTTTTTT
TTT. Second round PCR for H2AFJ up CAT-
GAATTCGCGGCCGTAAAGAGTTTGTAGA and down
AGTAAGCTTTCACCAACTTTATTGGCTCC; and for
RPS9 up CATGAATTCCTCTTTCTCAGTGAC and down
AGTAAGCTTTTTGTAAAGCGCTGA. The IFNA5 DNA
clone (MHS1010-98052299/Clon Id.7939602) was pur-
chased from Open Biosystem. The three plasmids
(pGEM3Z-IFNA5, pGEM3Z-H2AFJ and pGEM3Z-RPS9)
were digested with Hind III to provide RNA transcripts
700, 658 and 714 nts in length. Shortened DNA templates
for each gene were obtained by PCR using the corre-
sponding recombinant pGEM3Z DNA as template and
synthetic oligonucleotide as primers. The upstream
oligonucleotide contained the T7 promoter sequence linked
to the specific sequences. These were: IFNA5 197 EcoRI
T7-TCTCTCCTTTCTCCTGCCT and Hind III-TCCAC
TCCAACCTCCTGCAT; IFNA 215 EcoRI T7-TGAAGG
ACAGACATGACTT and Hind III-TCATACAGGCT
TCCAGGTCAT; and IFNA5 329 EcoRI T7-TCAGCACA
AAGGACTCATC and Hind III-TCATACAGGCTTC
CAGGTCAT; T7 H2A 415 TAATACGACTCACTAT
AGGGACCATCGCTCAGGGCGGCGTC; T7 H2A 451
TAATACGACTCACTATAGGGCTGCTGCCCAAGAA
GACGGA; H2A 657 (-)CACCAACTTTATTGGCTCCC;
H2A 609 (-)CTAGATGTCACCGGCCCTCC; H2A 643
(-)GCTCCCGCCGGGACCCTC; T7 RPS9 8 TAAT
ACGACTCACTATAGGGCAGTGACCGGGTGGTTTG
CT; T7 RPS9 27 TAATACGACTCACTATAGGGTTA
GGCGCAGACGGGGAA; T7 RPS9 159 TAATAC
GACTCACTATAGGGTATGGGCTCCGGAACAAAC
GT; RPS9 236 (-)CAGTTCCCGGGCGGCCTT; RPS9
215 (-)GATCTTGGCCAGGGTAAAT.
The fragments resulting after transcription were IFNA5
RNA (197–446), (215–427) and (397–427); H2AFJ RNA
(415–657), (456–657), (456–643) and (456–609) and RPS9
RNA (8–236), (27–215), and (159–215).
To obtain internally labelled substrates, 50-end-labelling
and 30-end-labelling reactions, for the cleavage assays, we
followed the protocol was described in Ref. [45].
The nucleotide sequences for the transcripts used in the
study are obtained from the GeneBank database under
accession numbers NM_177925.1 (H2AFJ), NM_001013
(RPS9) and NM_002169 (IFNA5).
Synechocystis sp. RNA ribozyme preparation
Plasmid pT76803 containing Synechocystis sp. PCC6803
RNase P RNA [46] was digested with Dra I to provide a
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transcript of 437 nts. A total of 2 lg of DNA template were
then transcribed using the MEGAscript kit (Ambion) and
the RNA purified using MEGAClearTM (Ambion) columns.
Its activity was titrated against internally labelled pre-
tRNATyr. Small aliquots were then stored at -80 C until
further use. The presence of cytosines in the 30 terminal
sequence in the substrate are not important for the activity
of Synechocystis sp. ribozyme as it occurs with M1 RNase
P ribozyme from E.coli [20, 47, 48].
Human liver mRNA poly(A) and Poly-r(A)
Human liver mRNA poly(A) (Ambion) was prepared from
DNase-treated total RNA purified twice by oligo dT-cel-
lulose chromatography.
Partial purification of human RNase P
RNase P activity was determined using 30 g of human
HeLa cells (Cilbiotech) purified following the procedure
described by Bartkiewicz et al. [49], as modified by Nadal
et al. [33], thus allowing the presence of significant RNase
MRP in our RNase P peak activity to be excluded.
RNase P cleavage and competitions assays
Standard reactions were performed as previously described
in [33] for human RNase P and [33, 34] for the Synechocystis
sp. ribozyme, respectively. For competitions using human
RNase P, we established an RNase P cleavage inhibition
assay in which specificity was monitored in order to deter-
mine whether mRNAs from human liver contain structural
motifs that competed with tRNA. These inhibition reactions
were performed in the linear range for conversion of pre-
tRNATyr into its products (around 40–50 %; non-saturated
reactions Fig. 1). The substrate concentration employed for
human RNase P assays (0.9 nM) was lower than the Km (10
nM) reported for the activity purified using the same pro-
cedure [50]. Synthetic poly-r(A) (ROCHE) was used as
unspecific inhibitor. To establish a molar ratio for the RNA
competitors, we assumed an average length of 2250 nts for
the mRNA population and 3000 nts for poly-r(A). The in-
hibition by this polymer of the pre-tRNATyr reaction by yeast
RNase P is intermediate between those for poly-r(U) and
poly-r(G) or poly-r(C) [51].
RNase P cleavage inhibition: quantification
and representation
Quantitative data relating to human RNase P digestion
were obtained using an Amersham Biosciences Storm
PhosphorImager, and quantified using the Image Quant 5.2
software (Molecular Dynamics). The cleavage percentage
was calculated as the ratio of cleavage products/starting
material ? cleavage products. The values for the different
RNA inhibitors were normalized by dividing the rate of
product formation in the absence of inhibitor and repre-
sented using the GraphPad software (Prism). The data fit to
the normalized rate of product formation is given by m1/
(1 ? (i)/(Ki)) ? m3, where m1 is the normalized activity
in the absence of inhibitor, (i) the inhibitor concentration,
[Ki] the concentration of inhibitor at 50 % inhibition, and
m3 the activity extrapolated to saturating inhibitor [52].
Visualizing mRNA population integrity
The profile of the mRNA population before and after in-
cubation with RNase P activities was evaluated using the
automated electrophoresis technique under denaturing
conditions with an ExperionTM (Bio-Rad).
Differential screening in microarrays
The Genomics Service at the Centro de Regulacio´n
Geno´mica in Barcelona was responsible for all amplifica-
tion procedures, labelling the digested RNAs, hybridization
and subsequent statistical analysis of data. Human liver
mRNA poly(A) samples (500 ng), digested or not with
RNase P activities, were amplified by in vitro transcription
using the Amino Allyl MessageAmp RNA amplification kit
(Ambion). Human Genome 20 K-G4110B (Agilent tech-
nologies) was employed for the screening study. The
microarrays were hybridized with dye-labelled RNA after
amplification of 500 ng of human liver mRNA incubated, or
not, with the Synechocystis sp. ribozyme at 67.5 nM. Each
series consisted of a duplicate hybridisation of dye and dye-
swap RNAs. An aliquot of each reaction mixture (control
and treated) was incubated in parallel in the presence of two
radioactively labelled substrates (HCV RNA 1-570 and pre-
tRNATyr). This control reaction allowed us to follow
cleavage by polyacrylamide gel electrophoresis, which
showed that the reaction was complete for pre-tRNATyr, in
the expected range of around 10 % for HCV RNA for the
ribozyme reaction, and barely detectable for the human
RNase P reaction (data not shown).
RNA end-group analysis and reactions to determine
specificity of the cleavage sites
The IFNA5 (1–700) RNA substrate was labelled at low
specific radioactivity to permit an increase of incorporated
radioactivity in the subsequent end-labelling reactions,
after cleavage with RNase P. The product bands were gel
purified and the radioactivity recovered divided into
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aliquots [45]. Each aliquot was then subjected to specific
enzymatic reactions to determine the chemical groups at
the 50- and 30-ends. For the 50-end, the RNA was incubated
with T4 polynucleotide kinase and [c-32P] ATP with or
without phosphatase pre-treatment as described [45]. For
the 30- and 50-P ends (circular RNA), the product band was
incubated with T4 RNA ligase described in Ref. [45]. The
reaction products were separated on 4 % denaturing poly-
acrylamide gels and visualized by autoradiography.
Structural determination using end-labelled RNAs
Enzymes
Single- and double-stranded RNA-specific digestion was
carried out under standard conditions, namely, 1000 CPMs
of end labelled RNAs incubated: 20 min at 37 C for RNase
T1 (0.001 lg/lL) (Calbiochem), 30 min at 37 C for
RNase V1 (0.0001 U/lL) (Ambion), 1 min 30 s at 37 C
for RNase A (0.0001 ng/lL (Ambion), and 15 min at 37 C
for E. coli RNase I (0.01U/lL). RNase concentrations were
previously calibrated to give partial cleavage and were run
in parallel to: (1) an alkaline degradation sample by heating
the RNA during 90 s at 95 C under conditions which in-
troduced an average of one cleavage per molecule, and (2) a
RNase T1 degradation of the RNA transcript under dena-
turing conditions at 55 C during 5 min with (0.005 lg/ll).
The specificities of the enzymes used for structural analysis
are as follows: RNase T1 after unpaired G, pancreatic
RNase A after unpaired pyrimidines (C and U), RNase V1
cleaves after any nucleotide either base-paired or single-
stranded but stacked [53, 54], and E. coli RNase I cleaves
are favoured after any single-stranded nucleotide.
Chemical reagents
Two specific reagents, namely diethylpyrocarbonate
(DEPC), which modifies adenines at the N7 position, and
Pb2?, which cleaves ssRNA and shows decreased reac-
tivity after guanines, were used.
DEPC modifications were performed under three con-
ditions: native conditions (standard reaction conditions at
10 mM HEPES–KOH pH 7.5, and 100 mM NH4OAc),
semi-denaturing conditions (10 mM HEPES–KOH pH 7.5,
1 mM EDTA and 100 mM NH4OAc) and denaturing
conditions. Modification by DEPC was performed ac-
cording to Peattie and Gilbert [55]. Reaction mixtures of
200 lL containing the appropriate buffer, labelled tran-
scripts (1000 CPM), 10 lL of pure DEPC and 10 lg of
tRNA from yeast, were incubated at 30 C for 10 min.
Incubation at 95 C for 5 min was used in the case of
denaturing conditions. After rounds of purification, mod-
ified bases were cleaved with aniline [55].
Pb2? reactions were carried out under two different
conditions of time and temperature: 30 C for 20 s, which
provided generalized reactivity, and 4 C for 15 min, in
which only a few bases were reactive. Both reactions were
performed using 40 mM of Pb(OAc)2 pH 7.2 and 1000
CPMs of end labelled transcripts. Products were analysed
on denaturing urea gels at two concentrations of poly-
acryalmide (6 and 10 %), and exceptionally also at 15 % as
indicated.
Structural determination using internally labelled
RNA
Internally radiolabelled RNAs were digested for 20 min at
37 C by addition of 0.01 mg/mL RNase T1 (Calbiochem),
an amount that was found to be sufficient to give complete
digestion of IFNA5 RNAs under standard buffer and salt
conditions. The reaction products were subjected to 15 %
denaturing polyacrylamide gel electrophoresis. Several
products considered to be resistant to complete RNase T1
digestion were eluted from this gel and re-digested to
completion in a new RNase T1 incubation in 10 mM Tris–
HCl pH 7.5 and 1 mM EDTA pH 7.5 for 20 min at 37 C
(secondary digestion). The products of each secondary di-
gestion were re-run in parallel with ‘‘sequence’’ markers in
26 % denaturing acrylamide gels. To obtain the RNA se-
quence markers, four DNA synthetic oligonucleotides 20 to
25 nts in length sequentially comprising most of the RNA
sequence subjected to analysis (positions 329–427) and
carrying the T7 promoter were transcribed in vitro in the
presence of [a-32P]GTP or [a-32P]UTP and purified on
20 % denaturing polyacrylamide gels. The DNA oligonu-
cleotides were:
T7-IFNA5 349-328 (-): CAGATGAGTCCTTTGTGC
TGACCCTATGAGTCGTATTA; T7-IFN5A 388-364 (-):
CAGTGTAGAATTTGTCTAGAAGTGTCCCTATAGTG
AGTCGTATTA; IFNA5 399-374 (-): CTGGTAAAGTT
CAGTGTAGAATTTGTCCCTATAGTGAGTCGTATTA;
T7-IFN5A 400-418 (-): CTTCCAGGTCATTCAGC
TGCCCTATAGTGAGTCGTATTA.
The gel-purified transcripts were totally digested with
RNase T1, and their products identified on the basis of their
relative migration pattern and differential labelling inten-
sity depending on whether they were ‘‘G’’ or ‘‘U’’ labelled.
In the 26 % polyacrylamide electrophoretic run, the re-
digestion lane for the protected RNA species gives a more
or less complex mixture of products that can be identified
by comparison of their mobility with the corresponding
digestion product of the marker.
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Sequencing of RNase P cleavage products
Direct RNA sequencing
End-labelled RNase P cleavage products were run in de-
naturing 6 % polyacrylamide gels in parallel to alkaline
degradation and RNase T1 ladder of the same RNA tran-
scripts prepared as described in the previous paragraphs.
Indirect sequencing
Indirect DNA sequencing was employed to sequence
IFNA5 (1–700) RNA cleavage products of human RNase
P. Addition of a track of poly(A) or poly(U) to the new 30-
end products of RNase P, or cyclising those RNA products
that present a new 50-end, allows us to use a complemen-
tary oligonucleotide to prime cDNA synthesis, followed by
RT-PCR, cloning using pGEM-T Easy (Promega), and
Sanger sequencing analysis.
Results
Analysis of the presence of human RNase P cleavage
sites in liver mRNAs by enzymatic competition
We tested the ability of increasing amounts of human liver
mRNA to compete for RNase P cleavage of the natural pre-
tRNATyr substrate internally labelled with [a-32P]GTP
(Fig. 1a). The results of this experiment were compared
with those for an assay in which cold pre-tRNA substrate
was used to compete with its labelled form (Fig. 1b).
Synthetic poly-r(A), which is not a substrate for RNase P
[56], was used to evaluate the non-specific competition
effect by increasing the amount of RNA in the reaction
mixtures (Fig. 1c).
The amount of cold pre-tRNATyr required for half-in-
hibition of cleavage was 4.36 ± 1.6 nM, whereas liver
mRNA was a stronger inhibitor (half-inhibition at
0.63 ± 0.17 nM; Fig. 1d). In contrast, when the inhibitory
Fig. 1 Competitive inhibition of pre-tRNATyr processing by human liver
mRNA in a standard RNase P reaction. Precursor tRNATyr (pre-tRNATyr:
131 nt)was radiolabelled internally and treatedwith humanRNaseP in the
absence or presence of increasing RNA competitors. For all panels, lane 1
shows pre-tRNA incubated on ice (I), lane 2 pre-tRNA in the presence of
reaction buffer (B), and lane 3 the control reaction with human RNase P
(R). Lanes 4–8 competitive pre-tRNA cleavage with a human liver
mRNA,b cold pre-tRNATyr and c poly-r(A), at amolar ratio of: 1:0.5, 1:1,
1:10, 1:25, and 1:50, respectively. Arrows indicate the main reaction
products: tRNATyr (88 nt) and a small 50-fragment (43 nt). d Graphical
representation of the pre-tRNATyr cleavage percentage in the presence of
human liver mRNA (black circles), pre-tRNATyr (grey triangles), and
poly-r(A) (unfilled squares) as competitorRNAs.Datapoints represent the
average of triplicate experiments ± standard deviation. Measurements
were normalized taking the control reaction as 100 %of cleavage activity,
and adjusted to the equation described in the ‘‘Materials and methods’’
section. The data for poly-r(A) did not fit the equation significantly. e As
above, except that the cleavage percentage is represented as a function of
the competitor RNAweight and the data are not adjusted.Autoradiograms
correspond to denaturing polyacrylamide gels at 10 %
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activity was expressed in terms of mass, 4.8 times more
mRNA than cold pre-tRNATyr was needed to reach half-
inhibition (Fig. 1e). Synthetic poly-r(A) was the least
competitive in both cases. Considered together, these re-
sults indicate that the observed inhibition of pre-tRNATyr
processing by human liver mRNA is at least partially
specific and also point to a molecular similarity between
the internal motifs embedded within mRNA and pre-tRNA.
Nevertheless, the cleavage-product distribution after hu-
man RNase P treatment of mRNA showed no changes with
respect to the control when visualized by automated de-
naturing electrophoresis (Fig. S1). This indicated that liver
mRNA species either did not contain built-in significant
RNase P-susceptible tRNA cleavable motifs or, if present,
they were not cleaved at a sufficiently high level to be
detected by automated electrophoresis.
Selection of a subset of three candidate mRNAs
and direct evaluation of RNase P processing
of the transcripts in vitro
We subsequently tried to identify the individual mRNA
species within the bulk liver mRNA that carried RNase P
cleavage sites in a microarray screening. Details are de-
scribed in Fig. S2. The in vitro transcribed and purified
Synechocystis sp. RNase P ribozyme was employed be-
cause of its purity with respect to human RNase P extract,
and because similar substrate specificity between human
Fig. 2 Specific cleavage of IFNA5, H2AFJ and RPS9 RNAs by
human RNase P. All transcripts were internally radiolabelled during
in vitro transcription. The RNA substrate for lanes 1–3 for all panels
is the pre-tRNATyr of E. coli. Lanes 4–9 correspond to: IFNA5 RNA
(1–700) for a, H2AFJ RNA (1–658) for b and RPS9 RNA (1–714) for
c. In all autoradiograms: lanes 1 and 4 correspond to RNAs incubated
on ice (I); lanes 2 and 5 in the presence of reaction buffer (B); lanes 3
and 6 reaction with human RNase P (R). Lane 7 human RNase P
reaction incubated with a tenfold molar excess of cold pre-tRNATyr.
Lane 8 incubated with 400 pg of a non-specific competitor poly-r(A).
This corresponds to the amount of RNA by weight used in the tenfold
pre-tRNATyr treatment in lane 7. Lane 9 molecular weight markers.
The main digestion products are indicated by arrows on the left of
each panel. The autoradiograms correspond to denaturing polyacry-
lamide gels at 4 %
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RNase P and Synechocystis RNase P has been found
previously in HCV [34, 57, 41] both are independent
of –CCA sequence in the substrate. A list of these genes
and their characteristics can be found in Table S1. We
selected three short mRNAs, *700 nts in length, to allow
analysis of the full length of the cleavage products through
gel electrophoresis, and to represent evolutionarily
separated activities. These mRNAs were: ribosomal RPS9,
histone H2AFJ and a member of the interferon alfa
subtype.
The results obtained upon digesting each of the in vitro
transcript RNAs with human RNase P are presented in
Fig. 2 and after digesting with Synechocystis sp. ribozyme
in Fig. S3; cleavage reactions were run in parallel with
specificity test reactions or in dose–response assays, re-
spectively. In light of the electrophoretic profiles and
intensity of the cleavage band products for human RNase
P cleavage, we could tentatively assign two primary
RNase P cleavage sites for IFNA5 mRNA, at least one for
H2AFJ mRNA (see following section) and one for RPS9
mRNA. The cleavage percentage ranged from ap-
proximately 4–15 %. The percentage of cleavage products
for IFNA5 RNA from three independent experiments was
10.1 ± 2.9 % for P1 ? P7 and 14.4 ± 4.8 % for
P3 ? P5.
Cleavage characterisation: positioning
and shortening substrates
Differential RNA labelling (50-end, 30-end and internal la-
bel) afforded direct mapping of the cleavage sites within
the three mRNAs (Fig. 3a, Fig. S4A and B). Results are
represented schematically in Fig. 3b and Fig. S4C and D.
The shortest RNA fragments tested and which were ob-
served to be cleaved by human RNase P with the same
specificity than the full length mRNAs, were IFNA5
(215–427) RNA (Fig. 4), H2AFJ (456-643) RNA
(Fig. S5A) and RPS9 (27–215) RNA (Fig. S5B and C). On
average, minimal substrates were 195 nts long. Specificity
data were obtained by competitive analysis, as described
previously. In the case of IFNA5 RNA, additional dose–
response behaviour was observed for the cyanobacteria
ribozyme (Fig. 4d).
Determination of the IFNA5 mRNA RNase P
cleavages sites and chemical endgroup analysis
Endgroups
The characteristic RNase P endgroups were found in the
newly generated termini (i.e. 50-P for P5 and P7 products
and 30-OH for P1 and P3 products) using three different
assays that included phosphatase, kinase and ligase
treatment, as described in the ‘‘Materials and methods’’
section and Supplementary Fig. 6.
Sequencing
An understanding of the cleavage polarity and end-group
chemistry for each product RNA allowed us to design a
strategy to generate a template for the cDNA synthesis
primer. Bands P5 and P7 were circularised while enzymatic
addition of poly(A) and poly(U) were employed for bands
P1 and P3. Supplementary Fig. 7A summarizes the results
obtained for RT-PCR cloned products P1, P3, P5 and P7.
Cleavage was found to be distributed over several neigh-
bouring sites for all products rather than being pinpointed
as a specific single site. The most frequently identified
cleavage site positions were A376;A377 for P3, A377;A378
for P5, G488;A489 for P7 and A491;A492 for P1. Direct RNA
sequencing of the proximal cleavage site (between band
products P5 and P7) indicated that cleavage occurred ap-
proximately after base A377 (Fig. S8), which coincided
with cleavage at A377;A378 found for the most represented
product end-group of P5 in cDNA sequencing.
Structural analysis of the IFNA5 RNA
in the proximal RNase P cleavage site
The structure prediction model for interpreting the ex-
perimental analysis was the common secondary structure
observed for IFNA5 (197–446) in several mammals spe-
cies, obtained using the Centroid program (Fig. 5). This
model comprises a four-branched structure; domains are
connected by a central loop and are designated as domain 1
to domain 4 (D1–D4) in clockwise direction. Helices and
loops within each domain will be designated as stem (s) or
loop (l) followed by letters. Three RNA fragments were
analysed by chemical and enzyme probing experiments:
IFNA5 RNA (197–446), which contained domains D1 to
D4 and was cleaved by RNase P; IFNA5 RNA (215–427),
which contained domains D2 to D4 and was also cleaved
by RNase P, although at a slower rate; and IFNA5 RNA
(397–427), which contained D3 and D4, but was not
cleaved by RNase P even though it contains the cleavage
site. This three fragment mapping strategy, with each
fragment having successively one less domain, was previ-
ously used for TMV plant tRNA-like characterisation [58].
RNase probing reactions of 50- and 30-end-labelled
transcripts
IFNA5 RNA (197–446)
Figure 6 show images of the denaturing polyacrylamide
gels of the sequential base-sensitivity for RNases T1, V1
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and A for the IFNA5 RNA (197–446) fragment. In the case
of the 30-end-labelled transcript, E.coli RNase I probing
was also performed. Cleavages were mostly consistent with
the predicted structures of the individual stems of D1 to
D4, and also for the apical loops D2 and D3, although there
were discrepancies in either the junction of these domains,
in the apical loop of D4 or in the internal bulges (Fig. 5). In
a clockwise direction, these discrepancies were: (1) in the
Fig. 3 Mapping the cleavage sites in mRNA IFNA5. a Autoradio-
gram of human RNase P cleavage of internally radiolabelled (lanes
1–3), 50- (lanes 4–6) and 30 end-labelled (lanes 7–9) IFNA5
transcripts, respectively. Lanes 1, 4 and 7 RNA incubated on ice
(I); lanes 2, 5 and 8 RNA incubated in reaction buffer (B); lanes 3, 6
and 9 reactions with human RNase P (R). Lane 10 is a molecular
weight ladder. Arrows indicate the major digestion products, desig-
nated as P1, P3, P5 and P7. b Linear diagram of the IFNA5 substrate
transcript (1–700 nt) segmented every 100 nts. Grey areas indicate
the protein-coding region and white areas the untranslated flanking
regions. The final cleavage products (P1–P7) and (P3–P5) deduced
from the observed bands on a 4 % polyacrylamide electrophoresis gel
are represented below. c Synechocystis sp. RNase P ribozyme
digestion of internally radiolabelled (lanes 2–4), 50- (lanes 5–7) and
30 end-labelled (lanes 8–10) IFNA5 transcripts. Lane 1 molecular
weight ladder. Lanes 2, 5 and 8 RNA incubated on ice. Lanes 3, 6 and
9 RNA incubated in reaction buffer. Lanes 4, 7 and 10 reactions with
Synechocystis sp. ribozyme. Product bands migrating at similar
positions as human RNase P product are marked on the right-hand
side
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Fig. 4 Determination of RNase P minimal substrate and cleavage
specificity in the tRNA-mimic region 1. To delimit the human RNase
P minimal substrates in IFNA5 mRNA, shortened DNA templates
were obtained by PCR, T7 in vitro transcribed in the presence
[a-32P]GTP and subjected to cleavage. a Schematic representation of
shortened IFNA5 RNA transcripts (197–446), (215–427) and
(329–427). b Human RNase P activity test under standard conditions.
The three fragments were incubated on ice (lanes 2, 7 and 12), in
reaction buffer (lanes 3, 8 and 13), or in the presence of human RNase
P (lanes 4, 9 and 14). Unlabelled pre-tRNATyr (109 molar excess) or
poly-r(A) (equivalent quantity by weight) was added to the reaction in
lanes 5, 10 and 15 and 6, 11 and 16, respectively. Lanes 1 and 17 are
the century and decade molecular markers, respectively. c Cyanobac-
terial ribozyme dose–response essay. The three fragments were
incubated on ice (lanes 1, 6 and 11), in the presence of buffer (lanes
2, 7 and 12) or with bacterial ribozyme at 67.5 nM (lanes 3, 8 and 13),
337.5 nM (4, 9 and 14) and 675 nM (lanes 5, 10 and 15), respectively.
Lane 16 contains the century molecular markers
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two opposite sequences forming loop 2a: the first sequence
motif A221–A230 contained two strong and two moderate
RNase V1 cleavages, and the second motif A316–C325
contained a set of four mild RNase V1 cleavages in its
central portion, thus indicating that this region is more
complex than a single-stranded RNA bulged motif; (2) in
loop 4b, which is comprised of mild RNase V1 cleavages
and a coincident RNase T1 and RNase V1 mild cleavage at
G402; (3) the apical loop sequence 4c (positions A389–C396)
lacked the expected cleavages by single-stranded RNases;
and (4) the predicted single-stranded RNA junction region
between D1 and D4. This central region contained a stretch
of strong RNase V1 cleavages (C419CUG422), thereby rul-
ing out its single-stranded RNA nature.
Comparative analysis of the three RNA fragments
Structural data from the three IFNA5 RNA fragments
(197–446) (Fig. 6), (215–427) (Fig. S9) and (329–427)
(Fig. S10) were compared to obtain information about
possible interactions between the D1 to D4 domains that
could explain the detected incompatibilities.
The main difference between IFNA5 (197–446) RNA
and IFNA5 (215–427) RNA (Figs. 5, 7a) was the disap-
pearance of two strong RNase A cleavages; C333 and C335
in the junction between D2 and D3 for the case of IFNA5
(215–427) RNA and its mild RNase V1 cleavages in
C313AG315. The remaining differences were minimal,
supporting the idea that the fragments are structurally
equivalent.
The most important changes occurred between IFNA5
RNAs (197–446) and (215–427) (Figs. 5, 7a) on the one
hand and (329–427) (Fig. 7b) on the other. The most re-
markable of these changes was the disappearance of strong
RNase V1 cleavages after bases C420UGU423 and, to a
lesser extent, loss of slight RNase V1 cleavages in
G402CU404 in IFNA5 (329–427) RNA. As these changes
were not compensated by any other coherent changes that
might presuppose an internal refolding of shorter IFNA5
(329–427) RNA when alone, and as these two regions were
conflictive in the larger fragment IFNA5 (197–446) RNA,
it can be inferred that these sequences interact with other
sequences in domain 2 (common to IFNA5 (197–446) and
(215–427) RNAs), pointing to a pseudoknot structure.
When comparing the size of the three RNA fragments, a
particular alteration occurred in predicted stem 4a
(C367UU369 and opposite strandA416AG418). As domainsD1
and D2 are successively deleted, more RNase V1 cleavages
were observed, thus indicating that this region is highly
inaccessible for the enzyme in the complete fragment.
Chemical structure analysis
We performed reactions using 30-end-labelled RNAs,
which allowed us to partially map IFNA5 RNAs (197-446)
(Fig. 8) and (215–427) (Figs. S11 and S12, panels A and
Fig. 5 Summary of the enzymatic and chemical probing results for
IFNA5 RNA (197–446). Mapping data are depicted upon common
predicted secondary structure of different species using Centroid
program http://www.ncrna.org/centroidfold/. Enzymatic cuts are
showed as arrow heads (RNase T1), circles (RNase V1) and arrows
(RNase A). The bases modified by DEPC are indicated by rhomboids
and those cleaved by Pb2? by stars. Strong cleavages are indicated by
filled symbols and moderate ones by unfilled symbols. (?) and (-)
enhanced or protected cleavage in MgCl2. Numbers indicate nu-
cleotide positions. D domain, l loop, PK possible pseudoknot. In blue,
sequences participating in a predicted pseudoknot. Highlighted in
gray are CAR-E sequences
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B) and completely map IFNA5 RNA (329–427) (Fig. S11
and S12, panels C and D).
IFNA5 RNA (197–446)
Under restricted probing conditions, Pb? reactivity was
concentrated in the central part of internal loop 2a, at the
junction between D2 and D3 and in the apical loop of D3
(loop 3a). There was no Pb2?-mediated cleavage at all in
domain D4, even at its apical loop, despite unpaired sites
being predicted (Fig. 5).
Under native conditions, reactivity to DEPC was found
at bulged A299 in domain 2, at the D2–D3 junction region,
in apical loop 3a, internal loop 4a, apical loop 4c and at the
D4–D1 junction.
It is remarkable that, according to the base-paired pre-
diction and RNase V1 sensitivity, most basal stem residues
in domain D1, and all those in the stem of D3, were pro-
tected against modification by DEPC and Pb2?. This is
indicative of the high stability of these dsRNA regions. The
lack of reactivity of DEPC in internal loop 4b, which also
does not react with Pb2?, reflects a higher degree of
organisation.
There is no effect on DEPC reactivity in the absence of
Mg2? at the junction regions of the main helices. In con-
trast, bulged A299 and apical loops 3a and 4c at A352 and
A390, respectively, showed reduced reactivity in the ab-
sence of Mg2? ions.
Comparative analysis
Chemical probing of the three consecutively shortened
RNA fragments shown in Figs. 5 and 7 confirmed that they
share similar non-reactivity in the proposed stems and
Fig. 6 Enzymatic probing of the secondary structure of IFNA5 RNA
(197–446). a, b 50-[32P] end-labelled RNA. b, c 30-[32P] end-labelled
RNA. For a and b lane 1 is the RNA maintained on ice (I); lane 2
alkaline hydrolysis reaction (OH); lane 3 RNase T1 reaction under
denaturing conditions (T1L); lane 4 RNase T1 (T1), lane 5 RNase V1
(V1) and lane 6 RNase A (A) under standard conditions, respectively.
For c and d products digested with alkali (OH), RNase T1 under
denaturing conditions (T1L), RNase T1 (T1), RNase V1 (V1), RNase
A (A) and E. coli RNase 1 (1) under standard conditions were
analysed in lanes 1 to 6, respectively. Denaturing gels were at 10 (a),
6 (b and d) and 15 % (c) polyacrylamide. The numbers on the right
indicate the point of digestion cleaved by RNase T1 under denaturing
conditions (T1L), as identified with the help of the OH sequence
ladders run on the left
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reactivity in apical loop 3a, thereby supporting the overall
pattern of sensitivity to ribonucleases. The comparative
analysis also highlighted several reactivity changes
amongst different sized RNAs. Most of these changes in-
volved acquisition of DEPC reactivity on the shorter
IFNA5 RNAs (215–427) and (329–427), and some of them
coincided. Two remarkable changes observed when com-
paring the smaller RNA fragment IFNA5 (215–427) with
IFNA5 (197–446) were the loss of three Pb2? cuts in the
middle of internal loop 2a C318UU320 and the acquisition of
a DEPC reactive site at the flanking A322. Another im-
portant difference was the larger change in reactivity of
IFNA5 (329–427) RNA at junction D1–D4 in comparison
to IFNA5 (197–446) and IFNA5 (215–427) RNAs, which
acquired two successive Pb2? cuts at sequence C419C420
and a new DEPC reaction at the neighbouring site A424.
One prominent Pb2? site specific cleavage [59] was found
at base C439, at 4 C, but not at 37 C, indicating that the
specific structure that supported it was not stable.
Mg2? participation
Positions observed to have differential reactivity to DEPC
in the presence of Mg2? were: A316 and A331. The first is
found between the two contiguous sequences participating
in the pseudoknot (G312CAG315) and (C317CUU320) (see
below). The second corresponds to the nearest neighbour of
G332 and is located at the four-way junction, thereby sug-
gesting that Mg2? participates in both the four-way
junction motifs and in the pseudoknots.
RNase protection assay using internally labelled
RNAs
Specific RNA:RNA contacts may help to protect the se-
quences involved in such contact areas from complete
digestion by single-stranded ribonucleases [60, 61]. Thus,
another approach to structural comparison involves ana-
lysing the nucleotide sequences of prominent RNase T1-
resistant oligonucleotides obtained from complete diges-
tion of internally radiolabelled RNAs IFNA5 (197–446),
(215–427) and (397–427) (Fig. 9). Electrophoretic analysis
of RNase T1-resistant fragments revealed that the three
RNAs contained a common, large and highly resistant
fragment (bands size of s1 in Fig. 9a). Kinetic analysis of
these RNase T1 digestion products indicated that the main
resistant band for all three RNA fragments could be de-
tected after 5 min of a 20 min reaction (data not shown).
Fig. 7 Summary of the enzymatic and chemical probing results for IFNA5 RNAs (215–427) (a) and (329–427) (b). Idem as figure
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Using the data concerning the length of the RNase T1
resistant products obtained from the 20 % polyacrylamide
gels, together with identification of the secondary digestion
products (Fig. S13), the majority of the sequence of pro-
tected fragment s1 was identified (51 out of approximately
59 bases were localised) and placed within the primary
sequence of the IFNA5 (329–427) RNA fragment (Fig. 9b),
covering nearly all of domain D4. Thus providing evidence
of this domain’s presence. The sequence for m3 was
identified by the same process and found to be identical to
s1 (data not shown).
Structure probing of sequences carrying site-
directed mutations
Four-branched structure
Four mutant IFNA5 (197–446), RNAs were employed to
test whether predicted base pair disruptions did in fact alter
the presumed four-branched structure. One mutant was
generated for each branch, domains D1 to D4, and they
were referred to as Mut-1, Mut-2, Mut-3 and Mut-4, re-
spectively (see Fig. 10 for details). The structural effects of
Fig. 8 Chemical probing of 30 end-labelled IFNA5 RNA (197–446).
a, b DEPC probing. Lane 1 is the RNA maintained on ice (I). Lanes 2
and 3 are the products from digestion with alkali (OH) and RNase T1
under denaturing conditions (T1L), respectively. Products of aniline-
treated RNAs previously modified with DEPC under native condi-
tions (lane 4), semi-denaturing conditions (lane 5) and denaturing
conditions (lane 6). c, d Pb2? probing. Lane 1 is the RNA maintained
on ice (I). Lane 2 treatment with alkali (OH); lane 3 treatment with
RNase T1 under denaturing conditions (T1L); lane 4 treatment with
Pb2? at 48C for 15 min and lane 5 treatment with Pb2? at 308C for
20 s. Denaturing gels were at 10 % (a, c) or 6 % polyacrylamide (b,
d)
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these base substitutions were assayed on 50-[32P] end-la-
belled transcripts by RNases T1 and V1 digestions and
compared with the wild-type cleavage pattern sequence
(Figure S14 A and B). We grouped the observed alterations
of RNase T1 and V1 patterns in Table S2 according to
whether a base had an altered reactivity in only one of the
mutant sequences (specific mutant alteration) or whether
alterations were repeated in more than one mutant se-
quence (structure-sensitive positions). Specific RNase
cleavage alterations, which were placed in the opposite
strand to the mutated positions, either provoked the ap-
pearance of a new RNase T1 cleavage (G414 for domain
D4) or the disappearance of a RNase V1 cleavage (G216
and U343 for domains D2 and D3, respectively). These
alterations supported the proposed D2, D3 and D4 domains
in the helix junction region and are distinguished with
larger letters in Table S2 and represented in Fig. 11. The
experiment yielded no information about domain 1. Other
few specific reactivity alterations were present (Table S2)
but did not provide evidence of any further structures
relevant to the wild-type sequence. These changes must be
due to differences in the secondary or tertiary structure of
the reorganized mutant RNAs that alter the nature of sites
available for the nucleases in comparison with the wild-
type molecule. It is also noticeable that the regions of
IFNA5 RNA more distant from the four helix junction,
except G405 in Mut-4, are unchanged in their susceptibility
to attack by RNases T and V1. This is a direct support for
the stability for the end part of each domain and, indirectly
for the central four-way junction configuration.
Additionally, changes in each mutant included at least a
base reactivity alteration at the helix junction region of a
different domain to that in which the mutation was gen-
erated (e.g. Mut-1 alters base G332 at D2–D3 junction;
Mut-2 alters base G363 at D3–D4 junction; Mut-3 and Mut-
4 alters base G212 at D1–D2 junction). Particularly, Mut-4
alters the junction position of the 3 other domains (Table
S2 and Fig. 11). Also the reactivity of bases in the se-
quences forming the predicted pseudoknot were altered. In
most of these cases, the same position at the junction or the
predicted pseudoknot was modified in different mutants,
and so these positions belong to those previously classified
as structure-sensitive. This result, probably due to desta-
bilisation of the domains coaxial stacking and/or sterical
facilitation of nucleases access to the central helix junction,
greatly supported the proposed four-way junction structure.
bFig. 9 Regions of IFNA5 RNA subdomains protected from RNase
T1 digestion under native conditions. a Protection of IFNA5 RNAs
from RNase T1 digestion assay. Internally labelled IFNA5 RNAs
(197–446), (215–427) and (329–427) maintained on ice (lanes 1–3),
incubated with digestion buffer (lanes 4–6), or in the presence of
RNase T1 at saturated concentration (lanes 7–9). Prominent product
species like those indicated by arrows were eluted for further study
(supplementary Fig. 14). Denaturing gel was at 15 % polyacrylamide.
b Region protected from RNAse T1 digestion bases written in bold
are more protected from digestion with RNase T1 than the ones in
standard style. Numbers indicate the nucleotide positions
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Pseudoknot
The IPKnot program [62] predicted a pseudoknot between
contiguous sequences (G312CAG315) and (C317CUU320),
pairing with (C420UGU423) and (A337AGG340), respec-
tively. We focused on the first pair of annealing sequences
because it was across the junction and because bases
(C420UGU423) within domain D4 lost three RNase V1
cleavage in RNA fragments lacking D2, as well as gained
two Pb2? cleavages and a DEPC cleavage at nearest
neighbour A424, which could be a sign of interaction be-
tween the mentioned D4 bases and the complementary
sequence in D2: G312CAG315, as predicted. Therefore, we
analysed two individual PK mutants, referred to as Mut-
PK1 and Mut-PK2, plus a third one with compensatory
mutations, Mut-PK1?2 (Figs. 10, 11).
Changes in the probing pattern with RNase T1 in Mut-
PK1 and Mut-PK2 (Fig. S14C) were constrained to posi-
tion G312, at its neighbour sequence G339G340 and at G224
within the opposite strand. The single exception was po-
sition G332 in the helix junction region (Fig. 5). Alterations
to RNase T1 cleavage at positions G312 and G332 were
absent in complementary mutation Mut-PK1?2, indicating
restoration of the pseudoknot structure across the junction
studied. The altered RNase T1 positions and Gs: 224, 332,
340, (outside the pseudoknoted annealing sequences pro-
bed) in both Mut-PK1 and Mut-PK2 were not restored in
the Mut-PK1?2, indicating that structural reorganization in
the Mut-PK1?2 was somewhat distinct to the wt sequence.
In the case of RNase V1, alterations of Mut-PK1 and Mut-
PK2 sequences affected base positions A314 and
C318UUC321, that were re-established in PK1?2.
In conclusion, results from site-directed mutants con-
firmed annealing between bases (C420UGU423) and
(C420UGU423), previously predicted from nucleases as well
as from chemical analysis of different fragment length
RNAs, and lent support to the prediction of a contiguous
pseudoknoted structure (coloured regions of structure
shown in Fig. 7). In the resulting model, most of the po-
sitions previously qualified as displaying contradictory
reactivities in RNA fragment (197–446): (A221C222) and
(C419–G422), could be located within the pseudoknot.
Conformational analysis
Native 6 % non-denaturing polyacrylamide gels were used
for conformational analysis of the IFNA5 (197–446),
(215–427) and (329–427) RNAs (Fig. S15). A major band
was present in each of the three RNA fragments. The band
corresponding to IFNA5 (197–446) RNA was slightly
wider than those in the other two fragments in repeated
experiments. Parallel RNase T1 digestions were carried out
to check whether the two larger fragments with different
gel-band widths could also be distinguished by comparing
nearby lanes containing the digests of RNA fragments.
IFNA5 RNAs (197–446) and (215–427) provided very
similar patterns of partial digestion products (Fig. S16),
indicating that they have similar structures, in keeping with
the results obtained during probing experiments. Subtle
differences between the two fragments were restricted to
very weak bands (Fig. S16). These were interesting be-
cause they lay close to or within a flanking region of
possible RNA:RNA interaction. The differences were a
mild cleavage before A316 in the case of IFNA5 (197–446)
RNA, absent in the IFNA5 (215–427) RNA fragment, and a
mild cleavage before C333 in IFNA5 (215–427) RNA, ab-
sent in the IFNA5 (197–446) RNA fragment. The first
difference was previously observed during structural
probing (Figs. 7, 8); the second was not, but added to a
region of two strong RNase A cleavage differences (i.e.
C333 and C335).
Regions determining human RNase P cleavage
To correlate the structural defects of the mutant sequences
with requirements for human RNase P cleavage, the wt
sequence was digested with RNase P in parallel to Mut and
PK mutant sequences (Fig. 12). Two independent ex-
periments provided the same electrophoretic cleavage
pattern. Substitutions decreased the extent of cleavage of
Mut-1 to Mut-3 mutants, altered cleavage specificity in
Mut-2 and Mut-3—providing products of a slightly dif-
ferent length—and the cleavage was nearly abolished in
D4. PK mutants were not affected severely.
Similarities between IFNA5 and HCV tRNA-like
motifs
When seeking parallels at the secondary structural level,
the four-way junction regions of HCV RNA in basal stem
loop III (see Fig. 7 of Lyons and Robertson [37]) [63] and
the central core region of IFNA5 RNA (Fig. 5), from which
the four domains D1 to D4 emerge, participate in a pseu-
doknot across the helix junction region. In the primary
structure, the presence of a CAR-E sequence in HCV po-
sitions C292–G303, although with a single insertion of two
nts (ag) in the sequence (50CCUGAUagGGUG30) is re-
markable. This is located in a structurally equivalent
position to the IFNA5 tRNA-like, in one of the branches
and loops of the HCV tRNA-like domain.
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Discussion
RNase P recognizable and cleavable sites are present
in human liver mRNA
The use of enzymes or cell-extract preparations that
specifically cleave structured RNA regions within eukary-
otic hnRNA, viral and phage mRNA in vitro represented an
important study tool in the field of gene-expression
regulation in the 1970s and early 1980s. When such regions
were found, they provided important information regarding
the processing or function of the RNAs carrying them [64–
67]. As this data began to emerge, it was shown that in-
ternally labelled hnRNA contained little or no target sites
for RNase P from E. coli and HeLa cellular fractions [56,
68]. As these findings suggested that RNase P did not
participate in any of the steps in which mature mRNAs
were cleaved from longer primary transcripts, there seemed
to be no role for RNase P in mature mRNA turnover/
metabolism [56, 68]. Probably because of this fact, the
specificity and proportion, if any, of RNase P-sensitive
sites within eukaryotic mRNA species remains unknown.
The primary objective of the experiments described in
this study was to explore whether tRNA-like structures
reported for many viral RNA genomes exist in host
mRNAs. The results of our human RNase P competition
assays indicated the presence of RNase P recognizable
structures within the mRNA population, but direct ex-
amination of the incubation products of mRNA with RNase
P suggested that most mRNA species do not contain
cleavable RNase P sites. This is in agreement with pub-
lished results on the 1970s [43, 52]. Subsequently, low but
reproducible signal values for cleavage were observed for
the highly purified Synechocystis sp. RNase P ribozyme
through microarray screening in order to detect individual
species. Three mRNAs selected from the screening were
also found to be specific substrates for the human RNase P
enzyme. For both RNase P activities and for the three
RNAs tested, the proportion of cleavage products of the
RNA which entered into the reaction were around 10 % or
less. This low cleavage percentage might provide an ex-
planation for the difference between the competition and
cleavage experiments in mRNA populations, indicating
that most elements with RNase P recognizable structural
properties within mRNA are neither stable nor perfectly
shaped, while also being cleavable. Indeed, the presence of
an enzyme that can cleave mRNAs in the nucleus of the
eukaryotic cell should have represented an evolutionary
constraint by favouring imperfect or unstable tRNA-mimic
structures rather than perfect mimicking of cleavable mo-
tifs. Under this assumption, the frequency of tRNA-like
motifs within mRNA cannot be estimated from our results.
All that can be concluded is that RNA structural elements
carrying features of tRNA are present within mRNAs; they
may occupy different locations within the message chain
and may be present more than once in the same molecule.
However, whatever the specific role of these RNase
P-sensitive structures built into mRNA, their biological
importance for molecular communication can be
hypothesized.
The example of IFNA5 mRNA
We have focused our study on interferon-alpha subtype 5
mRNA as it is a liver-specific variant [69] that shows the
same tropism as HCV. In this particular case, RNase P
cleavage specificity was further determined by the preci-
sion of the cleavage site in sequencing analysis and by
characterising newly generated end-groups after 50-P and
30-OH cleavage, which are characteristic cleavages of
RNase P [12].
The cloverleaf structure
Nuclease probing results from both of the labelled ends of
three different fragment length RNAs showed a high level
of mutual agreement and provided strong evidence of a
secondary structure similar to a cloverleaf (Fig. 5). A small
number of contradictory reactivities were found, i.e. bases
that are simultaneously reactive to both paired and un-
paired probes or which do not concur with the predicted
secondary structure. Only four of these cases were con-
sidered especially relevant: RNase A at C397 could be
explained by ‘breathing’ of the short stem in which C397 is
located; RNases V1 at A221–C222, U305 and U437, were
located on internal loops between large dsRNA regions and
thus, do not seem to indicate a structure difference to that
which is proposed. In particular, the dsRNA region flank-
ing the internal loop where U305 resides was determined to
be a substrate for specific double-stranded nuclease E.coli
RNase III (Dı´az-Toledano et al. in preparation). This lends
cFig. 10 Secondary structure of IFNA5 RNA (197–446) wt and Mut-1
to Mut-4 summarizing enzymatic probing. Upper draw secondary
structure of IFNA5 RNA (197–446) recompiling the location of the
site-directed mutational changes in the individually analysed mutant
sequences. The yellow squares indicate mutations of Mut-1 to Mut-4
sequences. The blue circles are mutations in PK1 and PK2 and the
compensatory Mut-PK1?2 sequences. The nucleotide changes are
provided above the wild-type sequence. Results from RNase T1 and
RNase V1 partial digestion data from 50 end-labelled IFNA5 RNA
(197–446) are represented by arrowheads and circles, respectively.
Mut-1 to Mut-4 are depicted. Only new cleavage points or missing
cleavages specific for each of the single mutant sequences in relation
to wt are presented. Key changes in boxes. The results shown are from
analysing 10 % as well as 6 % denaturing polyacrylamide gels
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Fig. 11 Secondary structure of IFNA5 RNA (197–446) of PK mutant
sequences summarizing enzymatic probing. RNase T1 and RNase V1
partial digestion data from 50 end-labelled IFNA5 RNA (197–446) are
represented by arrowheads and circles, respectively. Mutant
sequences Mut-PK1 and Mut-PK2 and restored Mut-PK1?2 are
depicted. Key changes in boxes. The results shown are from analysing
10 % as well as 6 % denaturing polyacrylamide gels
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strong support to the idea that the altered base reactivity
does not represent a distortion of the structure proposed for
domain D2. RNase V1 also cuts at base stacked positions,
and this could be an explanation of RNase V1 cleavages in
apparent internal loops [53]. RNase V1 cleavages at posi-
tions (C419–G422) are considered differently (see
‘‘Pseudoknot’’ section). Chemical analysis also supported
the proposed structure.
The main conclusion from the structural analysis of the
three fragment lengths were the general similarity of the
nuclease mapping within the common sequence. Deletion
of D1, or D1 and D2, had little effect on the rest of the
structure thus indicating that the predictions were accurate
for these two domains. The most notable differences be-
tween fragments D2–D3–D4 and D3–D4 are due to the
presence of the pseudoknot.
Additional support for the structure proposed came from
the RNase T1 protection experiments. We observed a
strongly protected sequence approximately 59 nts in length
and which included nearly the whole of domain 4 and
seven ‘‘G’’ residues. The failure of ribonuclease T1 to
cleave after this number of ‘‘G’’ bases in nuclease saturated
reactions, irrespective of the size of RNA being analysed,
implies that this region has a self-protecting fold, providing
strong evidence that D4 is one of the domains.
Finally, in a mutational study, new RNase cleavages
correlated with specific changes in the opposite chain of the
secondary structure model for domains D2, D3 and D4 in
the junction region, thus in agreement with the proposed
structure. D1 analysis was uninformative.
Of the additional alterations that were observed, most
were classified as structure-sensitive positions either
grouped in the four-way junction or in the predicted
pseudoknot. In the four-way junction, mutation of each
domain could generate changes in other domains, probably
due to destabilisation of helices coaxial stacking and/or
sterical obstructions; this could facilitate the attack of nu-
cleases at the central helix junction. Bases G212, G332, G363,
on the D1–D2, D2–D3 and D3–D4 junctions, respectively,
had modified RNase T1 cleavage patterns; again, a strong
indicator supporting the cloverleaf structure and in turn the
four-way junction structure.
Regarding RNase P determinant motifs, RNase P
cleavage locates at position A377;A378 and thus within the
IFNA5 (329–427) RNA fragment, containing domain D3–
D4, but a larger fragment containing D2–D3–D4 is re-
quired for cleavage. This it implies that the sequences/
structures flanking domain D3–D4 should have relevant
roles in specifying human RNase P recognition. Domain 2
provides a third helix to the cloverleaf structure. Mutations
of each domain also indicated that D4 stem disruption had
the worst effects on cleavage reactivity. D2 and D3 stems
also contributed to recognition as their modification chan-
ged cleavage specificity positions and decreased the extend
of the processing reaction. The pseudoknot was not
essential for cleavage. In comparison to RNase P minimal
substrate, domain 3 would ‘‘represent’’ the T-stem and
T-loop of tRNA and domain 4 the acceptor stem [70].
The pseudoknot in IFNA5 might be responsible for the
adequate orientation of the branches, as in the tRNA-like
structure in TMV, where the helix junction is integrated
within a pseudoknot [58] although that is a three-way
junction element.
Conformational analysis
Native gels (Supplementary Fig. 15) showed a major band
for the different transcripts indicating the presence of a
single conformation or, at least, very similar ones. The fact
that the band for the larger IFNA5 (197–446) RNA frag-
ment was broader than those of IFNA5 RNAs (329–427)
and (215–427) RNAs suggests that this RNA fragment is
breathing at some key structural sites. This interpretation
Fig. 12 RNase P cleavage of IFNA5 RNA (197–446) RNA site-
directed mutants. Autoradiogram showing the RNase P specific
cleavage of seven different IFNA5 variants shown in this figure and
wild-type RNA
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was supported by the results from a parallel RNase T1
probing (Supplementary Fig. 16) that revealed greater ac-
cessibility of G315 which favours the idea of a subtle
instability of the RNA:RNA interaction forming the pseu-
doknot in the larger IFNA5 (197–446) RNA fragment.
IFNAs CAR signal
A CAR signal, which is able to interact with factors for
nuclear export and cytoplasmic stabilisation, has been
characterised within a conserved secondary structure re-
gion, in both IFNA1 and IFNB1 mRNAs [71]. When the
exact positions are extrapolated to IFNA5 RNA, the regions
occupied by CAR correspond to positions 242–424. This
region coincides significantly with the minimal region re-
quired for RNase P cleavage, namely IFNA5 RNA
(215–427). Functional CAR signals involve primary se-
quence elements (one to four) 10 nts in length, referred to
as CAR-E [72]. Here we determined that each CAR-E is
located in the extremity of domains 2 and 4 of the tRNA-
like motif, positions C264–G273 and C396–G405, highlighted
in grey in Fig. 5. Apart from this positional symmetry,
CAR-E adopts an equivalent secondary structure.
Similarities between IFNA5 and HCV tRNA-like
motifs
It is possible that the similarly placed recognition elements
for the human RNase P enzyme in these viral 50 UTR
domains including HCV, CSFV, BVDV and cellular IFNAs
mRNA, together with key consensus sequence, structural
similarities, and unconventional polarity of cleavage by
RNase P reflect the presence of a similar RNA signal for
the molecules that carry them. In these line of argument,
the common presence of Aly protein bound to 50 UTR of
HCV [73] and to IFNA CAR [71] might provide a clue of
the functional correlate for the structural mimicry found
between viral and host elements. Nevertheless, further
experiments will be needed to prove this hypothesis.
Whatever it means for molecular communication, our
results open the door to examining whether any of the
mRNA species identified could provide clues about the
advantages to the viruses of incorporating tRNA-mimick-
ing elements in their genomes, and in particular whether or
not HCV RNA, and other viruses that contain such ele-
ments in their genome, acquire properties from the host
‘‘CAR’’ mRNA signal.
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